Ansa macrolide synthesis preoaration of the aromatic portion of maytansine

Ansa macrolide synthesis preoaration of the aromatic portion of maytansine

Tetrahedron Letters No. 9, pp 775 - 776, ANSA 1977. Pergamon Press. Printed in Great Britain. MACROLIDE SYNTHESIS PREPARATION OF THE AROMATIC ...

120KB Sizes 1 Downloads 101 Views

Tetrahedron Letters

No. 9, pp 775 - 776,

ANSA

1977.

Pergamon Press.

Printed

in Great Britain.

MACROLIDE SYNTHESIS

PREPARATION OF THE AROMATIC PORTION OF MAYCANSINE

James E. Foy and Bruce Ganem *

Department of Chemistry Cornell Ithaca,

University

New York

(Received in USA 30 Deoember 1976; received Progress requires

towards the stereospecific

an efficient

route to the tetrasubstltuted 2

in these ansa macrolides. selectlon

of an appropriate

route are three features the development 8, a versatile

synthesis

which considerably

of a six-step intermediate

in UK for publication

of clinically aromatic

An unusual assemblage nitrogen protecting

14853

interesting

(“western”)

28 January 1977) maytansinoids

fragment commonly

of three different

vicinal

found

heteroatoms , the

group, and the need for a preparatively

complicate

_$_I

practical

In this letter we disclose

this objective.

route to 2-chloro-3-methoxy-5-bromomethyl-N-methylacetanilide

which satisfies

our present prerequisites

for maytansine

total syn-

thesis. 7”” N - COCH3

CH3

CH2X

Condensation 2. (mp 118-119O)

of 5-methylcyclohexane-I

in 70% yield after crystallization.

with N-chlorosuccinlmide [72%,

mp 188-89’;

,3-dfone 3 with 40% aqueous

(1 equiv)

4

Chlorination

7.00

(broad 8, lH, 775

furnishes

of 2 is best accomplished

in CH2C12 at rt, and the resulting

NMR 6 (DMSO -d8)

methylamine

NH), 2.89

chloroenaminoketone (d, 3H, J=S), 1.08

2

No. 9

776 (EI) M + 173,

(d, 3H, J=6); mass spectrum

175, ratio

3:1] oxidized

further by the addition

of

Br2 in CC14 (1 equiv) at 0’.

Cl

P ‘qRTH3

2. R, R’=H 2 R=Cl,

R’=H

3 R=Cl,

R’=Br

3.15

[64%,

CH3

mp 123-124’;

treated directly Thus the overall 3H, N-m3), 5.62,

yield of S4

2.33

However

phenol

ated _i_n

(CH31, K2C03,

6.87,

(2 singlets,

(s, 3H, Ar-CQ13),

from 3 is 85-90%

1.81

group may be effected

(EI) M+ 255,

3.95

Conversion

3H),

3.18

(s, 3H),

of 8, now available

under investigation.

4

not purified,

dehydrobromination.

4 (mp 199-200°)

yield by reaction

[ NMR (CDC13) 7.05 1.82

(ED m/e

(s, 2H),

3.18

(s, 3H, N-COCH3);

(s, 3H, 0C_H3), 3.18

C_H-Br),

rather the mixture is

Saponification

Finally oxidation

F3,

mass spectrum

6 hr reflux) to give methoxyacetanilide

in 76-80%

CH,Br),

(d, lH,

[mp 88O; NMR (CDC13) 7.00

257 ratio 3:1].

(s, 3H. N-COCA3)].

4-5 hr, sunlamp irradiation) (s,

4 is usually

6.3u;

and Ar- CH3), 1.80

each lH, Ar - H), 3.92

(reflux,

lH, NH_), 4.81

IR (CHC13) 6.1,

5 which may be isolated

CH30H,

selectively

(broad s,

from which one isomer CrYs-

at 110’ for 90 min to effect

(broad s, 6H, 0-COCH3

the corresponding

6.78

(d, 3H, p6);

anhydride/l’sOH

6 .OOu; mass spectrum

affords

4 is formed in this reaction

ratio 1:1.06:0.31]. with acetic

3

CH3

NMR (CDC13) 5.7

(d, 3H, J=5, N - CH3), 1.18

251 (M+):253:255

I

R”~-c;;&)CH3

A mixture of monochlorobromides tallizes

CH

I

(s,

IR (mull)

of 2 (K2C03,

CH30H)

or preferably

methyl-

Z. [91%; NMR (CDC13) 3H, N-Cx3),

of 2 at the aromatic

with NBS (1.1 equiv)

(2 overlapping

(s,

s, 2H),

2.38 methyl

in Ccl4

4.44

(s, 2H,

(s, 3H)].

in good overall

yield

(33%),

into maytansine

is currently

5

REFERENCES (1) S.M. Kupchan, A.R. Branfman, A.T. Sneden, A.K: Varma, R.G. Dailey Jr., Y. Komoda, Y. Nagao, J. Amer. Chem. Sot., 97, 5294 (1975). (2) For other progress reports on maytansine see (a) A. I. Meyers et. , Tetrahedron Lett. , 717 (1974), 1745 (1975), 1749 (1975); (b) E.J. Corey, M.G. Bock, j&j., 2643 (1975) (3) A.W. Crossley, N. Renouf, J. Chem. Sot 602 (1915) (4) Satisfactory elemental analysis has been obtained for this compound. (5) The authors acknowledge generous financial support from the National Institutes of Health (Grant # CA 19686) and the Eli Lilly Company.